探索黑色素瘤的转移：新西兰二十年的分析。

Exploring melanoma shifts: a two-decade analysis in New Zealand.

机构信息

Department of General Surgery, North Shore Hospital, Te Whatu Ora - Health New Zealand Waitematā, New Zealand.

Department of Epidemiology and Biostatistics, School of Population Health, Faculty of Medical and Health Sciences, The University of Auckland, New Zealand.

出版信息

N Z Med J. 2024 Jun 7;137(1596):35-42. doi: 10.26635/6965.6430.

DOI:10.26635/6965.6430

PMID:38843548

Abstract

AIMS

New Zealand melanoma incidence rates are amongst the highest in the world. The study aims to provide information on the incidence of cutaneous melanoma in New Zealand from 2000 to 2022.

METHODS

De-identified data were extracted from the New Zealand Cancer Registry using the ICD-10 code for malignant melanoma (C34) and melanoma in situ (MIS) (D03) from 2000 to 2022. Statistical analysis was performed to calculate melanoma incidence rates.

RESULTS

Invasive melanoma (IM) incidence rates demonstrated an increasing trend from 2000 to 2008 (+1.10 per 100,000 person-years per year), followed by an inflection point at 2008 and then a decreasing trend from 2008 to 2022 (-0.28 per 100,000 person-years per year), which was not statistically different from zero/no change. MIS incidence increased from 30.3 to 72.1 per 100,000 person-years between 2000 and 2022.

CONCLUSIONS

The incidence of IM in New Zealand has plateaued in the last decade and was associated with an increase in MIS incidence over the same period. While this trend is encouraging, further research is required to investigate whether there is an actual decline in IM incidence.

摘要

目的

新西兰的黑色素瘤发病率位居世界前列。本研究旨在提供 2000 年至 2022 年新西兰皮肤黑色素瘤发病情况的信息。

方法

从新西兰癌症登记处提取了 2000 年至 2022 年使用国际疾病分类第 10 版恶性黑色素瘤 (C34) 和原位黑色素瘤 (MIS) (D03) 编码的去识别数据。进行了统计分析以计算黑色素瘤发病率。

结果

侵袭性黑色素瘤 (IM) 的发病率从 2000 年至 2008 年呈上升趋势 (每年每 10 万人年增加 1.10)，然后在 2008 年出现拐点，随后在 2008 年至 2022 年呈下降趋势 (每年每 10 万人年减少 0.28)，与零/无变化无统计学差异。MIS 的发病率从 2000 年的 30.3 增加到 2022 年的 72.1 每 10 万人年。